Ads
related to: sanofi- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Search results
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 3 hours agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 23 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Reuters via Yahoo News· 6 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
Charles River and Sanofi collab to replace animals with virtual controls in preclinical research
FierceBiotech· 2 days agoCharles River Laboratories and Sanofi are working on a new project in which virtual control animals...
A salty diet may increase eczema in adults, study finds
Washington Post· 19 hours agoAdults who eat a salty diet appear to have a higher risk for eczema, according to a study by...
My Novavax stock price forecast was correct: what next now? | Invezz
Invezz· 1 day agoNovavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 18 hours agoNovavax is also benefiting from investments from Sanofi (SNY), as the French pharma giant looks to license Novavax's platform and has taken a minority...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 3 days agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 3 hours agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 1 day agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.